Top Page
DC Two Ltd.
(Sydney:AI1)
DC Two Ltd. (AI1) vs. iShares MSCI Australia ETF (EWA)
DC Two Ltd. Business Overview & Revenue Model
DC Two Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.26M | 3.26M | 5.50M | 2.68M | 4.39M |
| Gross Profit | 1.64M | -781.61K | 3.21M | 1.44M | 1.46M |
| EBITDA | -6.35M | -5.69M | -106.12K | -1.52M | -2.96M |
| Net Income | -9.60M | -9.60M | -1.55M | -2.04M | -4.34M |
Balance Sheet | |||||
| Total Assets | 46.96M | 46.96M | 4.60M | 8.68M | 6.70M |
| Cash, Cash Equivalents and Short-Term Investments | 6.96M | 6.96M | 299.14K | 676.81K | 600.67K |
| Total Debt | 280.28K | 280.28K | 2.84M | 3.76M | 3.67M |
| Total Liabilities | 1.32M | 1.32M | 5.79M | 8.66M | 6.57M |
| Stockholders Equity | 45.64M | 45.64M | 2.31M | 2.19M | 2.24M |
Cash Flow | |||||
| Free Cash Flow | -4.66M | -4.66M | -800.60K | -1.28M | -3.80M |
| Operating Cash Flow | -3.65M | -3.65M | 0.00 | 0.00 | 0.00 |
| Investing Cash Flow | -1.90M | -1.90M | 801.22K | 21.85K | -2.45M |
| Financing Cash Flow | 12.21M | 12.21M | -429.50K | 1.01M | 2.51M |
DC Two Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | AU$16.91M | -0.39 | -148.39% | ― | ― | ― | |
47 Neutral | AU$27.27M | -9.88 | -60.87% | ― | ― | ― | |
44 Neutral | AU$31.91M | -14.50 | ― | ― | 7.32% | 67.11% | |
43 Neutral | AU$54.22M | -3.17 | -27.06% | ― | ― | ― |
DC Two Ltd. Corporate Events
Adisyn Ltd has requested and been granted a trading halt on its securities by the ASX, effective from 2 January 2026, pending the release of an announcement updating shareholders and the market on the progress of its low-temperature Atomic Layer Deposition research and development program. The halt, expected to last until either 6 January 2026 or the earlier release of the update, underscores the potential material significance of the R&D milestone associated with Tranche 1 Performance Rights for investors and highlights that forthcoming developments in the ALD program could influence the company’s valuation and strategic positioning in advanced materials technology.
Adisyn Ltd has disclosed a change in the interests of director Arye Kohavi, covering both his direct and indirect holdings in the company’s securities. Following shareholder approval at the 26 November 2025 AGM, Kohavi was issued an additional 4.2 million performance rights expiring 9 January 2026, 6.3 million expiring 9 July 2026 and 10.5 million expiring 9 January 2028, all for no cash consideration, significantly increasing his performance rights while leaving his indirect holding of 15.3 million escrowed fully paid ordinary shares unchanged; the move further aligns his remuneration with Adisyn’s future performance metrics and underscores a long-term incentive structure for senior leadership.
Adisyn Ltd has disclosed changes to the equity interests of director Kevin Crofton, detailing an increase in his holdings of performance rights and confirmation of existing options and ordinary shares. The additional performance rights, which were granted for no cash consideration following shareholder approval at the 26 November 2025 AGM, significantly expand Crofton’s potential equity stake, underscoring the company’s ongoing use of equity-based incentives to align executive remuneration with shareholder interests.
Adisyn Ltd has notified the ASX of the issue of 30 million unquoted performance rights under its AI1AM security code, effective 23 December 2025. The new performance rights issuance is likely tied to incentive or remuneration structures and will expand the company’s unquoted equity base, with potential implications for future dilution and alignment of management or staff interests with shareholder outcomes.
Adisyn Ltd, listed on the ASX under the code AI1, has reported a change to its capital structure following the expiry of a series of options. The company announced that 1,000,000 options exercisable at $0.60 and due to expire on 20 December 2025 have lapsed unexercised, resulting in a cessation of these securities, which marginally simplifies Adisyn’s capital structure and removes a potential future source of equity dilution for existing shareholders.
Adisyn Ltd has completed a strategic review of its asset portfolio and concluded that there are significant opportunities to improve scale and unlock value by directing more capital toward its graphene-based semiconductor subsidiary, 2D Generation. As a result, the company is now exploring options to realise shareholder value from its Adisyn Services managed IT and cybersecurity business, including the potential for a sale, partnership or change-of-control transaction, following inbound interest from third parties; while no agreements have yet been reached, the move signals a clear shift in focus toward Adisyn’s semiconductor technology and could reshape its business mix and growth profile in the semiconductor and IT services markets.
Adisyn Ltd announced that all resolutions proposed at its Annual General Meeting were successfully passed by poll. The resolutions included the adoption of the remuneration report, re-election of a director, approval of a 10% placement facility, refresh of the employee securities incentive plan, and issuance of options and performance rights to directors. This outcome reflects strong shareholder support and positions the company to continue its strategic initiatives.
Adisyn Ltd has requested a trading halt on its securities pending the release of an announcement regarding important initial pre-clean surface treatment results. The halt is expected to last until the announcement is made or until normal trading resumes on November 17, 2025. This move indicates that the company is preparing to disclose potentially significant information that could impact its stock performance and stakeholder interests.
Adisyn Ltd has announced a strategic review of its Adisyn Services business unit to align with its long-term strategy and maximize shareholder value. This review will evaluate the growth and scale potential of its subsidiary, 2D Generation, which develops graphene-based semiconductor technology, alongside Adisyn Services. The company has been focusing on improving Adisyn Services’ financial performance and growth, targeting Australian SME defense businesses with high-value IT and cybersecurity services. The strategic review reflects Adisyn’s ongoing efforts to capitalize on opportunities within the semiconductor industry.
Adisyn Ltd has reported significant progress in its quarterly activities, highlighting a strong financial position with A$6.0 million in cash and no debt. The company has completed a major facility upgrade and installed a Beneq TFS 200 Atomic Layer Deposition (ALD) system at its research facility in Israel, which is pivotal for advancing its proprietary low-temperature graphene deposition process. This development is crucial for overcoming existing performance barriers in semiconductor interconnects. The dual ALD-based graphene R&D activities at 2DG and Tel Aviv University facilities are expected to accelerate the validation of graphene films, enhancing the company’s industry positioning and potential impact on stakeholders.
Adisyn Limited has announced its upcoming Annual General Meeting (AGM), which will be held virtually on November 26, 2025. The company has opted to distribute the Notice of Meeting electronically, encouraging shareholders to access the document online and submit proxy forms in advance if they are unable to attend. This move reflects a shift towards digital communication, potentially enhancing shareholder engagement and streamlining administrative processes.
Adisyn Ltd announced its participation in the Semiconductor Australia conference and an investor roadshow. At the conference, the company will update on its progress in developing low-temperature graphene technology to address copper interconnect limitations in semiconductor manufacturing. This initiative is part of Adisyn’s strategy to enhance its position in the semiconductor industry and engage with investors to discuss its advancements and future plans.
Adisyn Ltd has announced a change in the director’s interest, specifically involving Mr. Blake Burton. The change includes the acquisition of 1,500,000 ordinary shares as a result of the partial vesting of T1 Performance Rights and the disposal of 1,500,000 T1 unvested Performance Rights and 2,000,000 T2 Performance Rights due to a milestone not being achieved. This adjustment results in Burton Capital Holdings Pty Ltd holding a total of 17,916,028 fully paid ordinary shares.
Adisyn Ltd has announced the issuance of 1,500,000 fully paid ordinary shares following the conversion of Tranche 1 Performance Rights to a company director. These performance rights were approved during the Annual General Meeting in November 2023 and are set to expire at the end of December 2025. The company has made this issuance without disclosure to investors under Part 6D.2 of the Corporations Act and confirms compliance with relevant provisions of the Act, ensuring no excluded information is present.
ADISYN LTD has announced the cessation of certain securities due to the lapse of conditional rights, as the conditions for these rights were not met. This announcement may impact the company’s capital structure and could have implications for stakeholders regarding the company’s ability to meet certain performance conditions.
Adisyn Ltd has announced the application for the quotation of 1,500,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code AI1. This move signifies a strategic step for Adisyn Ltd, potentially enhancing its market presence and providing additional liquidity for stakeholders.